Psychological and behavioural impact of returning personal results from whole-genome sequencing: The HealthSeq project

European Journal of Human Genetics

Volumn 25, Issue 3, 2017, Pages 280-292

  Sanderson, Saskia C ^a,b,c   Linderman, Michael D ^a   Suckiel, Sabrina A ^a   Zinberg, Randi ^a   Wasserstein, Melissa ^d   Kasarskis, Andrew ^a   Diaz, George A ^a   Schadt, Eric E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC VARIABILITY; HEALTH SURVEY; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACOGENOMICS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RARE DISEASE; SOCIAL BEHAVIOR; TELEPHONE INTERVIEW; WHOLE GENOME SEQUENCING; YOUNG ADULT; ADOLESCENT; AGED; DNA SEQUENCE; ETHICS; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC SCREENING; HUMAN GENOME; INTERPERSONAL COMMUNICATION; PATIENT; PATIENT ATTITUDE; PSYCHOLOGY;

ADOLESCENT; ADULT; AGED; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENTS; SEQUENCE ANALYSIS, DNA; TRUTH DISCLOSURE;

EID: 85008385061     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2016.178     Document Type: Article

References (50)

1. Choi M, Scholl UI, Ji W et al: Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci USA 2009; 106: 19096-19101
2. Stranneheim H, Wedell A: Exome and genome sequencing: a revolution for the discovery and diagnosis of monogenic disorders. J Intern Med 2016; 279: 3-15
3. Manolio TA, Abramowicz M, Al-Mulla F et al: Global implementation of genomic medicine: we are not alone. Genet Med 2015; 7: 290ps213
4. Niemiec E, Howard HC: Ethical issues in consumer genome sequencing: use of consumers' samples and data. Appl Transl Genom 2016; 8: 23-30
5. Dewey FE, Grove ME, Pan C et al: Clinical interpretation and implications of wholegenome sequencing. JAMA 2014; 311: 1035-1045
6. Flinter F: Should we sequence everyone's genome? No. BMJ 2013; 346: f3132
7. Gonzaga-Jauregui C, Lupski JR, Gibbs RA: Human genome sequencing in health and disease. Annu Rev Med 2012; 63: 35-61
8. Angrist M: Personal genomics: where are we now? Appl Transl Genom 2016; 8: 1-3
9. Gonzalez-Garay ML, McGuire AL, Pereira S, Caskey CT: Personalized genomic disease risk of volunteers. Proc Natl Acad Sci USA 2013; 110: 16957-16962
10. Moore B, Hu H, Singleton M, De La Vega FM, Reese MG, Yandell M: Global analysis of disease-related DNA sequence variation in 10 healthy individuals: implications for whole genome-based clinical diagnostics. Genet Med 2011; 13: 210-217
11. Grosse SD, Khoury MJ: What is the clinical utility of genetic testing? Genet Med 2006; 8: 448-450
12. Foster MW, Mulvihill JJ, Sharp RR: Evaluating the utility of personal genomic information. Genet Med 2009; 11: 570-574
13. Turrini M, Prainsack B: Beyond clinical utility: the multiple values of DTC genetics. Appl Transl Genom 2016; 8: 4-8
14. Kong SW, Lee IH, Leshchiner I: Summarizing polygenic risks for complex diseases in a clinical whole-genome report. Genet Med 2015; 17: 536-544
15. Lewis KL, Hooker GW, Connors PD: Participant use and communication of findings from exome sequencing: a mixed-methods study. Genet Med 2016; 18: 577-583
16. McLaughlin HM, Ceyhan-Birsoy O, Christensen KD et al: A systematic approach to the reporting of medically relevant findings from whole genome sequencing. BMC Med Genet 2014; 15: 134
17. Vassy JL, Lautenbach DM, McLaughlin HM et al: The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. Trials 2014; 15: 85
18. Bloss CS, Schork NJ, Topol EJ: Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med 2011; 364: 524-534
19. Grant RW, O'Brien KE, Waxler JL et al: Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial. Diabetes Care 2013; 36: 13-19
20. Weinberg DS, Myers RE, Keenan E et al: Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial. Ann Intern Med 2014; 161: 537-545
21. Marsaux CF, Celis-Morales C: Changes in physical activity following a genetic-based internet-delivered personalized intervention: randomized controlled trial (Food4Me). J Med Internet Res 2016; 18: e30
22. Meisel SF, Beeken RJ, van Jaarsveld CH, Wardle J: Genetic susceptibility testing and readiness to control weight: results from a randomized controlled trial. Obesity 2015; 23: 305-312
23. Sanderson SC, Humphries SE, Hubbart C, Hughes E, Jarvis MJ, Wardle J: Psychological and behavioural impact of genetic testing smokers for lung cancer risk: a phase II exploratory trial. J Health Psychol 2008; 13: 481-494
24. Hollands GJ, French DP, Griffin SJ et al: The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis. BMJ 2016; 352: i1102
25. McBride CM, Koehly LM, Sanderson SC, Kaphingst KA: The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors? Annu Rev Public Health 2010; 31: 89-103
26. Rogers RW: A protection motivation theory of fear appeals and attitude change. J Psychol 1975; 91: 21
27. Phillips AM: 'Only a click away-DTC genetics for ancestry, health, love. and more: a view of the business and regulatory landscape'. Appl Transl Genom 2016; 8: 16-22
28. Lunshof JE, Church GM, Prainsack B: Information access. Raw personal data: providing access. Science 2014; 343: 373-374
29. Middleton A, Wright CF, Morley KI et al: Potential research participants support the return of raw sequence data. J Med Genet 2015; 52: 571-574
30. Terry SF, Terry PF: Power to the people: participant ownership of clinical trial data. Sci Transl Med 2011; 3: 69cm63
31. Sanderson SC, Linderman MD, Suckiel SA et al: Motivations, concerns and preferences of personal genome sequencing research participants: baseline findings from the HealthSeq project. Eur J Hum Genet 2016; 24: 14-20
32. Suckiel SA, Linderman MD, Sanderson SC et al: Impact of genomic counseling on informed decision-making among ostensibly healthy individuals seeking personal genome sequencing: the HealthSeq Project. J Genet Couns 2016; 25: 1044-1053
33. Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley J: Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health 1993; 5: 179-193
34. Marteau TM, Bekker H: The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992; 31 (Pt 3): 301-306
35. Gandek B, Ware Jr JE, Aaronson NK et al: Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1149-1158
36. Cella D, Hughes C, Peterman A et al: A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol 2002; 21: 564-572
37. (CDC) CfDCaP: Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, GA, USA: US Department of Health and Human Services, CDC, 2006
38. Braun VC: Using Thematic Analysis in Psychology. Qual Res Psychol 2006; 3: 34
39. Ritchie JL: Qualitative Research Practice. A Guide for Social Science Students and Researchers. New Delhi/London: Sage/Thousand Oaks, 2003
40. Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ: Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 2005; 293: 43-53
41. Manrai AK, Funke BH, Rehm HL et al: Genetic misdiagnoses and the potential for health disparities. N Engl J Med 2016; 375: 655-665
42. Van Driest SL, Wells QS, Stallings S et al: Association of arrhythmia-related genetic variants with phenotypes documented in electronic medical records. JAMA 2016; 351: 47
43. Walsh RT, Thomson KL, Ware JS et al: Reassessment of Mendelian Gene pathogenicity using 7855 cardiomyopathy cases and 60,706 reference samples. Genet Med 2016; e-pub ahead of print 17 August 2016; doi:10.1038/gim.2016.90
44. Bloss CS, Schork NJ, Topol EJ: Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation. J Med Genet 2014; 51: 83-89
45. Feero WG, Green ED: Genomics education for health care professionals in the 21st century. JAMA 2011; 306: 989-990
46. Korf BR, Berry AB, Limson M et al: Framework for development of physician competencies in genomic medicine: report of the Competencies Working Group of the Inter-Society Coordinating Committee for Physician Education in Genomics. Genet Med 2014; 16: 804-809
47. Schadt EE: The changing privacy landscape in the era of big data. Mol Syst Biol 2012; 8: 612
48. Biesecker LG, Mullikin JC, Facio FM et al: The ClinSeq Project: piloting large-scale genome sequencing for research in genomic medicine. Genome Res 2009; 19: 1665-1674
49. Dowswell G, Ismail T, Greenfield S, Clifford S, Hancock B, Wilson S: Men's experience of erectile dysfunction after treatment for colorectal cancer: qualitative interview study. BMJ 2011; 343: d5824
50. Hersch J, Jansen J, Barratt A et al: Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ 2013; 346: f158